NCT06666075Completed
Digital Reminiscence Therapy for Alzheimer's in Institutionalized People
Psychological and Mental Health of Institutionalized People Over 60 Years of Age With Alzheimer's: Effects of a Digital and Interactive Reminiscence Program.
Source: ClinicalTrials.gov · Last updated 15 Aug 2025
Brief summary (registry, in English)
Digital reminiscence therapy (DRT) is an innovative intervention designed to enhance the psychological health of institutionalized seniors with Alzheimer's disease. This approach utilizes digital tools to facilitate the sharing of personal memories and experiences, fostering social interaction and emotional engagement. By combining technology with therapeutic reminiscence techniques, DRT aims to stimulate cognitive function and improve mood, potentially alleviating symptoms of anxiety and depression commonly observed in this population. Research indicates that reminiscence therapy can lead to improvements in quality of life and overall well-being for individuals with dementia. The interactive nature of digital platforms encourages participation and allows caregivers to customize content based on the individual's preferences and history. As such, DRT not only serves to strengthen the connections between seniors and their pasts but also enhances their current social interactions, promoting a sense of identity and belonging. Overall, DRT represents a promising avenue for addressing the psychological needs of older adults with Alzheimer's in institutional settings, highlighting the potential benefits of integrating technology into therapeutic practices.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 72 (actual)
- First submitted
- 28 Oct 2024
- Start date
- 20 Jan 2025
- Primary completion date
- 14 Apr 2025
- Lead sponsor
- University of Jaén
- Diseases
- Alzheimer disease
- NCT number
- NCT06666075
What you commit to
- Study type: Interventional
- Participants enrolled: 72
- From 20 Jan 2025 to the primary completion date, 14 Apr 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Diagnosis of other neurological or psychiatric conditions (such as vascular dementia, Parkinson's, or psychotic disorders) that may significantly interfere with the program's results.
Other
- Patients in advanced stages of Alzheimer's with severe limitations in remembering autobiographical events or interacting with digital devices.
- Vision, hearing, or fine motor problems that prevent the use of electronic devices in an appropriate manner, without the possibility of adaptation or assistance.
- Individuals or legal representatives who are unable or unwilling to give informed consent.
- Behaviors that may put the participant, staff, or other residents at risk when carrying out program activities.
Who the study is looking for
- People over 60 years of age.
- Confirmed diagnosis of mild or moderate Alzheimer's, where the patient still retains a certain degree of autobiographical memory.
- People institutionalized in a geriatric care center or similar.
- Level of cognitive impairment that allows understanding and basic interaction with digital tools.
- Approval and signature of informed consent by the participant or his/her legal representative, demonstrating agreement to participate in the study.
- Availability or access to devices (tablets or computers) provided by the study program or the care center.
Age in the registry: 60 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Miguel Ángel Fernández Sevilla Coordinator of this site? Confirm its status | Jaén | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.